Ahuva Cern
Jerusalem, JM, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Efficacy, pharmacokinetics and safety of liposomal synthetic cannabidiol injected subcutaneously in dogs: a randomized, blinded, placebo-controlled, crossover clinical trial.
Journal: Frontiers in veterinary science
Published: November 14, 2025
Liposomal-synthetic-cannabidiol: preliminary translational evidence of efficacy, tolerability and pharmacokinetics following repeated subcutaneous injections in two goats.
Journal: Frontiers in pharmacology
Published: August 20, 2025
Pharmacokinetics and tolerability of liposomal synthetic cannabidiol subcutaneous depot in Holstein dairy calves.
Journal: Journal of dairy science
Published: August 05, 2025
Advancing Medical Applications of Cancer Nanotechnology: Highlighting Two Decades of the NCI'S Nanotechnology Characterization Laboratory Service to the Research Community.
Journal: Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
Published: April 08, 2025
Nano-mupirocin as tumor-targeted antibiotic: Physicochemical, immunotoxicological and pharmacokinetic characterization, and effect on gut microbiome.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: March 06, 2024
Therapeutic efficacy and pharmacokinetics of liposomal-cannabidiol injection: a pilot clinical study in dogs with naturally-occurring osteoarthritis.
Journal: Frontiers in veterinary science
Published: May 17, 2023
A Case Report of Subcutaneously Injected Liposomal Cannabidiol Formulation Used as a Compassion Therapy for Pain Management in a Dog.
Journal: Frontiers in veterinary science
Published: March 08, 2022
Liposomal mupirocin holds promise for systemic treatment of invasive Staphylococcus aureus infections.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: July 04, 2019
In Vitro Susceptibility of Neisseria gonorrhoeae Strains to Mupirocin, an Antibiotic Reformulated for Parenteral Administration in Nanoliposomes.
Journal: Antimicrobial agents and chemotherapy
Published: November 22, 2017
New drug candidates for liposomal delivery identified by computer modeling of liposomes' remote loading and leakage.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: January 10, 2017
Effect of solubilizing agents on mupirocin loading into and release from PEGylated nanoliposomes.
Journal: Journal of pharmaceutical sciences
Published: January 07, 2014
Last Updated: 09/26/2026